Thuốc Sarsaparilla

0
88
Thuốc Sarsaparilla
Thuốc Sarsaparilla

Holevn Health share articles about :Thuốc Sarsaparilla  , side effects – dosage , Thuốc Sarsaparilla what disease treatment.Other noted issues. Please refer to the details below.

Scientific Name(s): Smilax aristolochiifolia Mill. (Mexican sarsaparilla), Smilax china, Smilax febrifuga Kunth (Ecuadorian sarsaparilla), Smilax officinalis Kunth (Honduras sarsaparilla), Smilax ornata Lem., Smilax regelii Killip et Morton (Honduras, Jamaican sarsaparilla), Smilax
Common Name(s): Ba Qia catbrier, Greenbrier, Jin Gang Teng, Khao yen, Rhizoma Smilacis Glabrae, Sarsa, Sarsaparilla, Smilace, Smilax, Zarzaparilla

Medically reviewed by Holevn.org. Last updated on Jun 21, 2019.

Clinical Overview

Use

Extracts of the roots may be effective in treating gout and metabolic syndrome; however, evidence is based largely on animal studies and clinical trials are limited. Sarsaparilla has been traditionally used for treating syphilis, leprosy, and psoriasis; however, evidence to support these uses is lacking. Evidence is also lacking for purported ergogenic/adaptogenic effects. Interest in cytotoxic potential in treating cancer exists.

Dosing

Clinical trials are lacking to provide guidance on therapeutic dosages. Typical sarsaparilla doses for a variety of uses range from 0.3 to 2 g/day of the powdered root.

Contraindications

Contraindications have not yet been identified.

Pregnancy/Lactation

Avoid use. Information regarding safety and efficacy in pregnancy and lactation is lacking. Estrogenic and antiestrogenic activities have been described for extracts of at least one of the species.

Interactions

None well documented.

Adverse Reactions

GI irritation and increased diuresis have been reported. Clinical studies are lacking to provide evidence (or lack of evidence) of harm.

Toxicology

Information regarding toxicology with the use of sarsaparilla is limited.

Scientific Family

  • Liliaceae
  • Smilacaceae (Catbrier)

Botany

Many Smilax species are very similar in appearance, regardless of origin. Sarsaparilla is a woody, trailing vine that can grow to 50 m in length. The nectar-rich flowers are used in honey production, and the root is used for medicinal purposes. The root has a pleasant fragrance and spicy sweet taste and is used as a natural flavoring agent in medicines, foods, and nonalcoholic beverages; however, the sarsaparilla root should not be confused with the sassafras tree, which is the source of the distinctive flavoring of American root beer.1, 2, 3

History

The Spanish physician Nicolás Monardes described using sarsaparilla to treat syphilis in 1574. In 1812, Portuguese soldiers suffering from syphilis recovered faster if sarsaparilla was taken to treat the disease versus mercury, the standard treatment at the time.4 Sarsaparilla has been used by many cultures for other ailments as well, including skin disorders, arthritis, fever, digestive disorders, leprosy, and cancer.1, 4 Late 15th century accounts of the identification and first descriptions of American drugs include sarsaparilla.5 Sarsaparilla was used as a medicinal plant in American and European remedies in the 16th century as well.6 Sarsaparilla has been used for treating syphilis and other sexually transmitted diseases throughout the world and was documented as an adjuvant for leprosy treatment in 1959.7 S. china (Ba Qia or Jin Gang Teng) was included in the 2010 Chinese Pharmacopoeia.8

Chemistry

The rhizomes and roots of the genus are of primary interest. Due to the diversity of the species, standardization of preparations is difficult.9

Smilax species contain a number of steroidal saponins, including sarsaponin, smilasaponin (smilacin), sarsaparilloside and its aglycones sarsasaponin (parillin), sarsasapogenin (parigenin), and smilagenin.1, 4, 10, 11 Other saponins include diosgenin, furostanol, tigogenin, and asperagenin,1, 10 as well as the phytosterols sitosterol, stigmasterol, and pollinastanol.1, 2 At least 50 phenolic compounds and flavonoids have been described.12, 13, 14, 15, 16, 17, 18 Flavonol glycosides, such as isoastilbin, isoengetitin, and astilbin, have been identified.19 Other constituents in sarsaparilla include starch (50%), resin, cetyl alcohol, volatile oil, caffeoylshikimic acid, shikimic acid, ferulic acid, sarsapic acid, kaempferol, and quercetin. Minerals reported in the genus include aluminum, chromium, iron, magnesium, selenium, calcium, zinc, and others.1, 2, 20, 21, 22

The berries contain large amounts of carotenoids (up to 375 mcg/g fresh weight), including lycopene, beta-carotene, cryptoxanthin,23 while the leaves contain phenolic and flavonoid compounds.24

Uses and Pharmacology

Anti-inflammatory

Animal data

In vitro studies report effects on inflammatory markers.22, 25, 26

Extracts of Smilax species have been shown to inhibit induced paw inflammation in rats26, 27 and antiproliferative activity in mice models of psoriasis.28

Clinical data

There are no clinical data regarding the use of sarsaparilla for anti-inflammatory effects.

Antioxidant

Animal data

Experiments report antioxidant activity for extracts of this genus.24, 29, 30, 31 Protective effects against oxidative stress and induced hepatotoxicity have been demonstrated.32, 33

Clinical data

There are no quality clinical data regarding the use of sarsaparilla for antioxidant activity.

Antimicrobial

Antimycotic activity has been described in a screening study.34 In vitro antimicrobial activity has been described for Smilax glabra rhizome extracts and Smilax campestris, including activity against Candida albicans.12, 35 Butanol extracts of S. china showed activity against HIV in vitro.36

Clinical data

There are no quality clinical data regarding the use of sarsaparilla for antimicrobial activity.

Cancer

Animal data

Studies with extracts for individual Smilax species have investigated cytotoxic activity against human cell lines (including cervical, hepatic, breast, gastric, and colon cancer), and induced tumors in mice.11, 37, 38, 39, 40, 41 In castrated mice with induced benign prostatic hyperplasia, extracts from S. china reduced dihydrotestosterone levels and histopathological examination reveals possible protective effect against prostate enlargement.8

Clinical data

Research reveals no clinical data regarding the use of sarsaparilla in cancer.

Cardiovascular/Metabolic syndrome

Animal data

In vitro studies suggest modulatory effects on endothelial dysfunction.42

Hypoglycemic effects have been demonstrated in mice, possibly via effects on inflammatory aspects of metabolic syndrome.43, 44 Astilbin protected against induced reperfusion injury in rats, possibly via modulation of proinflammatory markers.19 Astilbin and smitilbin from S. glabra, however, did not stimulate insulin secretion.45

In saline-challenged mice, Smilax canariensis (Canary Islands) increased diuresis similarly to hydrochlorothiazide and furosemide.46 S. glabra flavonoids inhibited induced intracellular calcium ion release in cardiomyoblast cells.47

Clinical data

There are no clinical data regarding the use of sarsaparilla in cardiovascular-related conditions.

CNS

Animal data

A study in mice with induced seizures reported an antiepileptic effect (increased seizure latency) for extracts of the rhizome of S. china.48

Clinical data

There are no clinical data regarding the use of sarsaparilla in CNS-related conditions.

Gout

Animal data

Several studies in hyperuricemic and hyperuricosuric rats have been conducted with positive findings. 49, 50, 51, 52, 53, 54, 55

Clinical data

Rhizoma Smilacis Glabrae, in combination with ash bark, has been studied in patients with gout. The “Rebixiao” preparation was effective in reducing serum uric acid levels56; however, the study had methodological limitations.57

Other uses

Sarsaparilla may bind to endotoxins; however, clinical studies are lacking.4 An older study conducted in the 1940s suggested sarsaponin improved psoriasis.58 The fact that the saponin sarsasapogenin can be synthetically transformed into testosterone bears no relevance in vivo. A review of more than 600 commercially available supplements determined that no research validated purported ergogenic claims.59, 60

Dosing

Clinical trials are lacking to provide guidance on therapeutic dosages. Typical sarsaparilla doses for a variety of uses range from 0.3 to 2 g/day of the powdered root.61, 62

Pregnancy / Lactation

Avoid use. Information regarding safety and efficacy in pregnancy and lactation is lacking. Estrogenic and antiestrogenic activities have been described for extracts of Smilax corbularia (Thai sarsaparilla).41

Interactions

Case reports are lacking. Hepatic induction of cytochrome P450 2A6 has been described for extracts of S. china species.63 An increased absorption of digitalis and elimination of hypnotics may be expected.64 An additive effect with diuretics and allopurinol might also be anticipated, based on animal studies.46, 53

Adverse Reactions

Clinical studies are lacking to provide evidence (or lack of evidence) of harm; however, traditional use of sarsaparilla, eaten raw or in soups and used in Chinese medicine, suggests safety at usual dosages.2, 38 GI irritation and increased diuresis have been reported.2, 60 Occupational asthma caused by sarsaparilla root dust has been reported.64

Toxicology

Information regarding toxicology with the use of sarsaparilla is limited.

References

1. Newall C, Anderson L, Phillipson J. Herbal Medicines: A Guide for Healthcare Professionals. London, England: Pharmaceutical Press; 1996:233-234.2. Duke J, Bogenschutz-Godwin M, duCellier J, Duke P. Handbook of Medicinal Herbs. 2nd ed. Boca Raton, FL: CRC Press; 2002.3. Smilax aristolochiifolia. USDA, NRCS. 2015. The PLANTS Database (http://plants.usda.gov, 2015). National Plant Data Center, Baton Rouge, LA 70874-4490 USA.4. Murray M. The Healing Power of Herbs. 2nd ed. Rocklin, CA: Prima Publishing; 1995:302-305.5. Estes J. The European reception of the first drugs from the New World. Pharm Hist. 1995;37(1):3-23.116395336. Elferink JG. The significance of pre-Columbian pharmaceutical knowledge for European medicine in the XVΙth century. Pharm Acta Helv. 1979;54(9-10):299-302.3905487. Rollier R. Treatment of lepromatous leprosy by a combination of DDS and sarsaparilla (Smilax ornata). Int J Lepr. 1959;27:328-340.144385298. Chen J, Xiong CM, Song SS, Han P, Ruan JL. Fraction of macroporous resin from Smilax china L. inhibits testosterone propionate-induced prostatic hyperplasia in castrated rats. J Med Food. 2012;15(7):646-650.225101019. Martins AR, Abreu AG, Bajay MM, et al. Development and characterization of microsatellite markers for the medicinal plant Smilax brasiliensis (Smilacaceae) and related species. Appl Plant Sci. 2013;1(6):apps.1200507.2520255510. Liang Y, Yao S, Liang F, et al. Structural characterization of steroidal saponins from Smilax trinervula using ultra high-performance liquid chromatography coupled with LTQ-Orbitrap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;974:75-82.2546320011. Xu J, Feng S, Wang Q, Cao Y, Sun M, Zhang C. Four new furostanol saponins from the rhizomes and roots of Smilax scobinicaulis and their cytotoxicity. Molecules. 2014;19(12):20975-20987.2551733912. Xu S, Shang MY, Liu GX, et al. Chemical constituents from the rhizomes of Smilax glabra and their antimicrobial activity. Molecules. 2013;18(5):5265-5287.2369804213. Bernardo RR, Pinto AV, Parente JP. Steroidal saponins from Smilax officinalis. Phytochemistry. 1996;43(2):465-469.886203814. Ju Y, Jia ZJ. Steroidal saponins from the rhizomes of Smilax menispermoidea. Phytochemistry. 1992;31(4):1349-1351.136805115. Kubo S, Mimaki Y, Sashida Y, Nikaido T, Ohmoto T. Steroidal saponins from the rhizomes of Smilax sieboldii. Phytochemistry. 1992;31(7):2445-2450.136938616. Okanishi T, Akahori A, Yasuda F. Studies on the steroidal components of domestic plants. XLVΙΙ. Constituents of the stem of Smilax sieboldi Miq. (1). The structure of laxogenin. Chem Pharm Bull (Tokyo). 1965;13(5):545-550.586771117. Jia ZH, Ju Y. Steroidal saponins from Smilax lebrunii. Phytochemistry. 1992;31(9):3173-3175.136841318. Sashida Y, Kubo S, Mimaki Y, Nikaido T, Ohmoto T. Steroidal saponins from Smilax riparia and S. china. Phytochemistry. 1992;31(7):2439-2443.136938519. Diao H, Kang Z, Han F, Jiang W. Astilbin protects diabetic rat heart against ischemia-reperfusion injury via blockade of HMGB1-dependent NF-kappaB signaling pathway. Food Chem Toxicol. 2014;63:104-110.2421174520. Chen G, Shen L, Jiang P. Flavanonol glucosides of Smilax glabra Roxb [in Chinese]. Chung Kuo Chung Yao Tsa Chih. 1996;21(6):355-357, 383.938892421. Li YQ, Yi YH, Tang HF, Xiao K. Studies on the structure of isoastilbin [in Chinese]. Yao Xue Xue Bao. 1996;31(10):761-763.986324422. Lu CL, Zhu YF, Hu MM, et al. Optimization of astilbin extraction from the rhizome of Smilax glabra, and evaluation of its anti-inflammatory effect and probable underlying mechanism in lipopolysaccharide-induced RAW264.7 macrophages. Molecules. 2015;20(1):625-644.2556951823. Delgado-Pelayo R, Hornero-Méndez D. Identification and quantitative analysis of carotenoids and their esters from sarsaparilla (Smilax aspera L.) berries. J Agric Food Chem. 2012;60(33):8225-8232.2282324624. Huang AC, Wilde A, Ebmeyer J, Skouroumounis GK, Taylor DK. Examination of the phenolic profile and antioxidant activity of the leaves of the Australian native plant Smilax glyciphylla. J Nat Prod. 2013;76(10):1930-1936.2405030025. Lu CL, Zhu W, Wang M, Xu XJ, Lu CJ. Antioxidant and anti-inflammatory activities of phenolic-enriched extracts of Smilax glabra. Evid Based Complement Alternat Med. 2014;2014:910438.2547799926. Ruangnoo S, Jaiaree N, Makchuchit S, Panthong S, Thongdeeying P, Itharat A. An in vitro inhibitory effect on RAW 264.7 cells by anti-inflammatory compounds from Smilax corbularia Kunth. Asian Pac J Allergy Immunol. 2012;30(4):268-274.2339390627. Ageel AM, Mossa JS, al-Yahya MA, al-Said MS, Tariq M. Experimental studies on antirheumatic crude drugs used in Saudi traditional medicine. Drugs Exp Clin Res. 1989;15(8):369-372.259877728. Vijayalakshmi A, Ravichandiran V, Malarkodi V, Nirmala S, Jayakumari S. Screening of flavonoid “quercetin” from the rhizome of Smilax china Linn. for anti-psoriatic activity. Asian Pac J Trop Biomed. 2012;2(4):269-275.2356991229. Park G, Kim TM, Kim JH, Oh MS. Antioxidant effects of the sarsaparilla via scavenging of reactive oxygen species and induction of antioxidant enzymes in human dermal fibroblasts. Environ Toxicol Pharmacol. 2014;38(1):305-315.2502235530. Yoon SR, Yang SH, Suh JW, Shim SM. Fermentation of Smilax china root by Aspergillus usami and Saccharomyces cerevisiae promoted concentration of resveratrol and oxyresveratrol and the free-radical scavenging activity. J Sci Food Agric. 2014;94(9):1822-1826.2491986931. Xia D, Yu X, Liao S, Shao Q, Mou H, Ma W. Protective effect of Smilax glabra extract against lead-induced oxidative stress in rats. J Ethnopharmacol. 2010;130(2):414-420.2058080532. Xia D, Fan Y, Zhang P, Fu Y, Ju M, Zhang X. Protective effects of the flavonoid-rich fraction from rhizomes of Smilax glabra Roxb. on carbon tetrachloride-induced hepatotoxicity in rats. J Membr Biol. 2013;246(6):479-485.2368135333. Murali A, Ashok P, Madhavan V. Effect of Smilax zeylanica roots and rhizomes in paracetamol induced hepatotoxicity. J Complement Integr Med. 2012;9:Article 29.2315242834. Caceres A, Lopez BR, Giron MA, Logemann H. Plants used in Guatemala for the treatment of dermatophytic infections. 1. Screening for antimycotic activity of 44 plant extracts. J Ethnopharmacol. 1991;31(3):263-276.205675535. Morais MI, Pinto ME, Araújo SG, et al. Antioxidant and antifungal activities of Smilax campestris Griseb. (Smilacaceae). Nat Prod Res. 2014;28(16):1275-1279.2470784936. Wang WX, Qian JY, Wang XJ, Jiang AP, Jia AQ. Anti-HIV-1 activities of extracts and phenolics from Smilax china L. Pak J Pharm Sci. 2014;27(1):147-151.2437444237. Gao Y, Su Y, Qu L, et al. Mitochondrial apoptosis contributes to the anti-cancer effect of Smilax glabra Roxb. Toxicol Lett. 2011;207(2):112-120.2192041738. Cao B, Zhang Z, Zhang Y, Li J, Liang G, Ling J. Effect of Smilax china L.-containing serum on the expression of POLD1 mRNA in human hepatocarcinoma SMMC-7721 cells. Exp Ther Med. 2013;6(4):1070-1076.2413731939. Wang WX, Li TX, Ma H, Zhang JF, Jia AQ. Tumoral cytotoxic and antioxidative phenylpropanoid glycosides in Smilax riparia A. DC. J Ethnopharmacol. 2013;149(2):527-532.2389220640. Wu LS, Wang XJ, Wang H, Yang HW, Jia AQ, Ding Q. Cytotoxic polyphenols against breast tumor cell in Smilax china L. J Ethnopharmacol. 2010;130(3):460-464.2066936541. Wungsintaweekul B, Umehara K, Miyase T, Noguchi H. Estrogenic and anti-estrogenic compounds from the Thai medicinal plant, Smilax corbularia (Smilacaceae). Phytochemistry. 2011;72(6):495-502.2131539242. Sang HQ, Gu JF, Yuan JR, Zhang MH, Jia XB, Feng L. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-kappaB pathway. J Ethnopharmacol. 2014;155(1):785-795.2495303343. Fukunaga T, Miura T, Furuta K, Kato A. Hypoglycemic effect of the rhizomes of Smilax glabra in normal and diabetic mice. Biol Pharm Bull. 1997;20(1):44-46.901380544. Amaro CA, González-Cortazar M, Herrera-Ruiz M, et al. Hypoglycemic and hypotensive activity of a root extract of Smilax aristolochiifolia, standardized on N-trans-feruloyl-tyramine. Molecules. 2014;19(8):11366-11384.2509012445. Nguyen KH, Ta TN, Pham TH, et al. Nuciferine stimulates insulin secretion from beta cells-an in vitro comparison with glibenclamide. J Ethnopharmacol. 2012;142(2):488-495.2263398246. Abdala S, Martin-Herrera D, Benjumea D, Gutiérrez SD. Diuretic activity of some Smilax canariensis fractions. J Ethnopharmacol. 2012;140(2):277-281.2228934647. Shou Q, Pan S, Tu J, et al. Modulation effect of Smilax glabra flavonoids on ryanodine receptor mediated intracellular Ca2+ release in cardiomyoblast cells. J Ethnopharmacol. 2013;150(1):389-392.2395428048. Vijayalakshmi A, Ravichandiran V, Anbu J, Velraj M, Jayakumari S. Anticonvulsant and neurotoxicity profile of the rhizome of Smilax china Linn. in mice. Indian J Pharmacol. 2011;43(1):27-30.2145541749. Giachetti D, Taddei I, Taddei E. Effects of Smilax macrophylla Vers. in normal or hyperuricemic and hyperuricosuric rats. Pharmacol Res Commun. 1988;(20)(suppl 5):59-62.324735450. Xu WA, Yin L, Pan HY, et al. Study on the correlation between constituents detected in serum from Rhizoma Smilacis Glabrae and the reduction of uric acid levels in hyperuricemia. J Ethnopharmacol. 2013;150(2):747-754.2414058851. Wu XH, Zhang J, Wang SQ, Yang VC, Anderson S, Zhang YW. Riparoside B and timosaponin J, two steroidal glycosides from Smilax riparia, resist to hyperuricemia based on URAT1 in hyperuricemic mice. Phytomedicine. 2014;21(10):1196-1201.2490816352. Wu XH, Yu CH, Zhang CF, Anderson S, Zhang YW. Smilax riparia reduces hyperuricemia in mice as a potential treatment of gout. Am J Chin Med. 2014;42(1):257-259.2446754853. Wu XH, Wang CZ, Wang SQ, et al. Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia, a traditional Chinese herbal medicine. J Ethnopharmacol. 2015;162:362-368.2561774654. Wu XH, Ruan JL, Zhang J, Wang SQ, Zhang YW. Pallidifloside D, a saponin glycoside constituent from Smilax riparia, resist to hyperuricemia based on URAT1 and GLUT9 in hyperuricemic mice. J Ethnopharmacol. 2014;157:201-205.2526758055. Chen L, Yin H, Lan Z, et al. Anti-hyperuricemic and nephroprotective effects of Smilax china L. J Ethnopharmacol. 2011;135(2):399-405.2142047856. Ji W, Zhu XX, Tan WF, Lu Y. Effects of Rebixiao granules on blood uric acid in patients with repeatedly attacking acute gouty arthritis. Chin J Integr Med. 2005;11(1):15-21.1597530157. Li XX, Han M, Wang YY, Liu JP. Chinese herbal medicine for gout: a systematic review of randomized clinical trials. Clin Rheumatol. 2013;32(7):943-959.2366631858. Rafatullah S, Mossa JS, Ageel AM, Al-Yahya MA, Tariq M. Hepatoprotective and safety evaluation studies on sarsaparilla. Int J Pharmacognosy. 1991;29(4):296-301.59. Grunewald KK, Bailey RS. Commercially marketed supplements for bodybuilding athletes. Sports Med. 1993;15(2):90-103.844682760. King DS, Baskerville R, Hellsten Y, et al. A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance-Part 34. Br J Sports Med. 2012;46(9):689-690.2271179861. Claus E, ed. Pharmacognosy. 3rd ed. Philadelphia, PA: Lea & Febiger; 1956.62. Gruenwald J, ed. PDR for Herbal Medicines. 2nd ed. Montvale, NJ: Thomson Medical Economics; 2000: 661-662.63. Kim KM, Suh JW, Yang SH, Kim BR, Park TS, Shim SM. Smilax china root extract detoxifies nicotine by reducing reactive oxygen species and inducing CYP2A6. J Food Sci. 2014;79(10):H2132-H2139.2522066364. Vogel JH, Bolling SF, Costello RB, et al; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). J Am Coll Cardiol. 2005;46(1):184-221.1599266265. Vandenplas O, Depelchin S, Toussaint G, Delwiche JP, Weyer RV, Saint-Remy JM. Occupational asthma caused by sarsaparilla root dust. J Allergy Clin Immunol. 1996;97(6):1416-1418.8648042

Disclaimer

This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

Further information

The content of Holevn is solely for the purpose of providing information about Thuốc Sarsaparilla  and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Please contact your nearest doctor or clinic, hospital for advice. We do not accept liability if the patient arbitrarily uses the drug without following a doctor’s prescription.

Reference from: https://www.drugs.com/npp/sarsaparilla.html

LEAVE A REPLY

Please enter your comment!
Please enter your name here